Drugs for diabetes and weight loss like Ozempic and Wegovy show promise in helping people quit smoking, offering a surprising extra benefit for users.
Compared to people who took other anti-diabetes drugs, like insulin, those who took semaglutide were up to 32% less likely to have medical visits that have to do with tobacco use disorder, according to .
Tobacco use disorder is the scientific term for a pattern of tobacco use that indicates dependence or addiction. For the study, researchers analyzed electronic health records of about 6,000 people with type 2 diabetes taking semaglutide, which is marketed under the brand name Ozempic to treat type 2 diabetes, and under the name Wegovy for overweight and obesity-related conditions. To gauge semaglutide’s impact on tobacco addiction, the researchers looked at whether people were diagnosed with tobacco use disorder during medical visits, were prescribed medication for smoking cessation, or whether they were referred to smoking cessation counseling. Besides being less likely to have a medical appointment related to a tobacco use disorder diagnosis, people taking semaglutide were also less likely than those on other anti-diabetes medicines to be prescribed smoking cessation drugs or to be referred for smoking cessation counseling.All of the people in the study newly began taking semaglutide between December 2017 and March 2023, and had not used any other anti-diabetes medicines in the year before starting semaglutide. The greatest effects were seen within 30 days of people starting semaglutide, but they continued for about 180 days, after which they typically plateaued. The researchers decided to examine the topic after numerous reports of people taking the medicine saying they had less desire to smoke. The findings are limited in that it was an observational study of people’s health care information and doesn’t reflect actual tobacco usage, cravings, or whether people quit smoking. Quitting smoking is also often linked to weight gain. But the authors noted that their findings are important because smoking is the top preventable cause of early death and contributes to some of the most of common diseases in the world, like heart disease and cancer. Nearly 12% of U.S. adults smoke. The reason that drugs like semaglutide may help people quit smoking is unclear, the authors wrote, but early research points toward the drug’s impact on the brain’s reward system. Other recent studies have linked semaglutide with benefits for people with Further study of the impact of semaglutide on tobacco use is warranted using more rigorous randomized controlled trials, the authors said, noting that these latest findings are not concrete enough to justify off-label use of semaglutide to help people quit smoking.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns website over unlawful sale of weight-loss drugsThe U.S. Food and Drug Administration said on Tuesday it had warned a website called ozempen.com against unlawfully selling versions of Novo Nordisk's weight-loss drugs.
Read more »
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindnessPeople who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn’t deter patients from using the medicines to treat diabetes or obesity.
Read more »
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye conditionNovo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.
Read more »
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye conditionNovo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.
Read more »
Weight Loss Drugs Cut Cancer Risk in Diabetes PatientsPeople with type 2 diabetes who took these drugs had a lower risk of having 10 out of 13 obesity-related cancers, compared with those who used insulin therapy.
Read more »
Ozempic, Weight Loss Drugs, and Vision Loss: What to Know About Recent StudyYou may have heard of type 1 and type 2, but there are many more types of diabetes you should know about. Here are six types, from gestational to monogenic.
Read more »